throbber
How to Prepare for Your Injection | Teva's Shared Solutions®
`
`24/7 SUPPORT
`
`1.800.887.8100
`
`
`
`Visit HCP Site
`
`
`
`Prescribing Information
`
`Important Safety Information
`
`Home > Taking Teva's COPAXONE > Preparation

`
`PREPARATION
`1
`Teva's COPAXONE (glatiramer acetate injection): Tips for preparing for your injection

`The following are some tips and suggestions for you and your CarePartner to help make your injection
` experience more positive. Before you inject for the first time, you should be trained by a health care
` professional, even if you have used an injectable therapy before. And remember, Teva’s Shared Solutions
` is always here for you to help you get started, or anywhere along the way.

`
`They sent someone to show me how to administer
` the injection, and continued to check on how
` things
`were going.
`
`-Georgina, Teva Survey Respondent
`
`If you have questions about your injections or would like refresher training, be sure to call Shared
` Solutions at 1-800-887-8100. And if you ever feel overwhelmed or uncertain, ask to speak with one of

` our multiple sclerosis (MS)–certified nurses. Our regular hours are 8:00 AM to 8:00 PM (CT), Monday
` through Friday, but a nurse is available 24/7 by phone for urgent needs. We’re here for you every step
` of the way.
`Organizing your supplies
`SHOW MORE
`Place each item you’ll need on a clean, flat surface. You can use the COPAXONE Preparation Mat to
`Important Safety Information

` help you organize your supplies.
`Do not take COPAXONE if you are allergic to glatiramer acetate or mannitol. Some patients report a short-term reaction right after injecting

` COPAXONE . This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety,

`Here’s what you’ll need for your injection:
` and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and do not require specific
` treatment.
`
`https://www.copaxone.com/injection-assistance/preparing-your-injection[3/7/2016 10:30:05 AM]
`
`MYLAN PHARMS. INC. EXHIBIT 1086 PAGE 1
`
`

`
`How to Prepare for Your Injection | Teva's Shared Solutions®
`
`1 COPAXONE Pre-filled Syringe

`The autoject 2 for glass syringe (if you’re using it)

`A warm compress (if you’re using it)
`An alcohol wipe
`A dry cotton ball
`A used-syringe disposal container
`Before injecting
`Always wash your hands before injecting.
`Remember—wait until your pre-filled syringe has reached room temperature before injecting.
`Some people find it helpful to use a warm compress before injecting.
`Clean your injection site with an alcohol wipe, and make sure your skin is dry before injecting.
`It may help to ice the site for 1 minute before cleaning the site and injecting.
`When injecting
`Avoid injecting into sites with birthmarks, tattoos, and/or skin irregularities.
`If there are particles in the syringe or the solution is cloudy, do not use it. Report this event to Shared
` Solutions .

`It is extremely important to rotate your injection areas (and sites within each area) to help keep your
` skin as healthy as possible.
`If you need more injection areas, or can’t inject in some areas, your doctor may be able to
` recommend other appropriate sites. Make an appointment with Shared Solutions at

` 1-800-887-8100 for free refresher training.
`Never inject with a needle that has been dropped on the floor or has come in contact with any other
` surface. Start over with a new syringe.
`After injecting
`Avoid hot showers or baths after you inject.
`Do not massage the site immediately after injecting—this can damage underlying tissue. Wait at
` least 24 hours after injecting.
`Dispose of used syringes in a hard-walled plastic or disposable biohazard sharps container
` immediately after you inject.
`If you miss a dose, take your COPAXONE as soon as you remember. If it is nearer to the time of

` your next scheduled dose, skip the missed dose and resume your usual dosing schedule.
`If you have any questions about missing a dose, contact Shared Solutions at 1-800-887-8100 or

` your healthcare provider for assistance.
`
`Watch this video to see the preparation of an injection for daily COPAXONE 20 mg. The preparation

` tips are applicable for 3-times-a-week COPAXONE 40 mg, as well.

`
`Please see full Prescribing Information.
`Have questions about preparing for your injections? Ask Claire, your Virtual Health Assistant, at the top right
` corner of this page.
`
`https://www.copaxone.com/injection-assistance/preparing-your-injection[3/7/2016 10:30:05 AM]
`
`MYLAN PHARMS. INC. EXHIBIT 1086 PAGE 2
`
`

`
`How to Prepare for Your Injection | Teva's Shared Solutions®
`
`Use the information in this section as a springboard for discussions with your health care provider and for
` your own research. Claire is not meant to provide medical advice or to replace the guidance of a doctor.
`back to top
`
`How to Start
`
`|
`
`Injecting with autoject 2 for glass syringe

`
`Show Conversation
`
`Voice: On
`Off
`
`STAY ON TRACK
`Type your question here...
`Track injections on your computer or smartphone.
`
`HOW TO START
`Ready to make the move to the 3-times-a-week dose?
`
`Use
`
`COPAXONE (glatiramer acetate injection) is prescription medicine used for the treatment of people with relapsing forms of multiple

` sclerosis (MS).
`Important Safety Information
`
`Do not take COPAXONE if you are allergic to glatiramer acetate or mannitol.

`
`Some patients report a short-term reaction right after injecting COPAXONE . This reaction can involve flushing (feeling of warmth and/or

` redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes
` of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of
` patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your
` area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe
` pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.
`
`Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few minutes. You may
` experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience
` chest pain that lasts for a long time or feels very intense.
`
`A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue.
` Be sure to follow proper injection technique and inform your doctor of any skin changes.
`
`The most common side effects in studies of COPAXONE are redness, pain, swelling, itching, or a lump at the site of injection, flushing,

` rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE . For a complete list, ask your

` doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE .

`
`https://www.copaxone.com/injection-assistance/preparing-your-injection[3/7/2016 10:30:05 AM]
`
`MYLAN PHARMS. INC. EXHIBIT 1086 PAGE 3
`
`

`
`How to Prepare for Your Injection | Teva's Shared Solutions®
`
`You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
`Please see full Prescribing Information for Teva’s COPAXONE .

`
`Terms of Use
`
`| Accessibility Help | Privacy Notice | Site Map | Contact Us
`
`CALL A MS-CERTIFIED NURSE
`
`Reference: 1. COPAXONE (glatiramer acetate injection) prescribing information. Rev. 1/2014. Teva Neuroscience, Inc.

`
`Injections for 3-times-a-week COPAXONE 40 mg should be at least 48 hours apart.

`
`†
`
`Applies only to daily COPAXONE 20 mg. Certain limits and restrictions apply.

`Terms and Conditions for daily COPAXONE include: COPAXONE Co-pay Solutions is open to both new and existing patients who are


` residents of the US or Puerto Rico and who have commercial prescription insurance coverage for COPAXONE 20 mg. The offer is not

` valid for patients covered in whole or in part by Medicaid, Medicare, TRICARE, or any other federal or state government pharmaceutical
` assistance plan or program (regardless of whether a specific prescription is covered), or by private health benefit programs that reimburse
` for the entire cost of prescription drugs. Use of this offer must be consistent with the terms of any drug benefit provided by a health insurer,
` health plan, or private third-party payor. This offer is void in Massachusetts and where otherwise prohibited by law, taxed, or restricted. No
` additional purchase is required. This offer is valid only at participating pharmacies and may be changed or discontinued at any time without
` notice. This program is not health insurance.
`
`††
`

`Applies only to 3-times-a-week COPAXONE 40 mg. Certain limits and restrictions apply.
`Terms and Conditions for 3-times-a-week COPAXONE include: COPAXONE Co-pay Solutions is open to both new and existing patients


` who are residents of the US or Puerto Rico and who have commercial prescription insurance coverage for COPAXONE 40 mg. The offer

` is not valid for uninsured patients or patients covered in whole or in part by Medicaid, Medicare, TRICARE, or any other federal or state
` government pharmaceutical assistance plan or program (regardless of whether a specific prescription is covered), or by private health
` benefit programs that reimburse for the entire cost of prescription drugs. Use of this offer must be consistent with the terms of any drug
` benefit provided by a health insurer, health plan, or private third-party payor. This offer is void in Massachusetts and where otherwise
` prohibited by law, taxed, or restricted. No additional purchase is required. This offer is valid only at participating pharmacies and may be
` changed or discontinued at any time without notice. This program is not health insurance.
`



` COPAXONE , COPAXONE CO-PAY SOLUTIONS , and COPAXONE iTracker are registered trademarks of Teva Pharmaceutical
` Industries Ltd.

` Shared Solutions is a registered service mark of Teva Neuroscience, Inc.
` COPAXONE webTracker™ is a trademark of Teva Pharmaceutical Industries Ltd.
`
`https://www.copaxone.com/injection-assistance/preparing-your-injection[3/7/2016 10:30:05 AM]
`
`MYLAN PHARMS. INC. EXHIBIT 1086 PAGE 4
`
`

`
`How to Prepare for Your Injection | Teva's Shared Solutions®
`
`autoject 2 for glass syringe is a registered trademark of Owen Mumford, Ltd. Available by prescription only.

` Apple and iTunes are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc.
` Android and Google Play are trademarks of Google Inc.
` © 2015 Teva Neuroscience, Inc. COP-43351 This site is intended for US residents only.
`
`https://www.copaxone.com/injection-assistance/preparing-your-injection[3/7/2016 10:30:05 AM]
`
`MYLAN PHARMS. INC. EXHIBIT 1086 PAGE 5

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket